Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Chardan Capital from $20.00 to $18.00. They now have a "buy" rating on the stock.
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy' Stocks [Yahoo! Finance]
Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation [Yahoo! Finance]